Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis

BACKGROUND: Emerging evidence indicates that RUNX3 is a candidate tumor suppressor in several types of human tumors, including non-small cell lung cancer (NSCLC). However, the correlation between RUNX3 hypermethylation and clinicopathological characteristics of NSCLC remains unclear. Here, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lijun, Lan, Hongwen, Su, Yushu, Li, Jun, Wan, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461130/
https://www.ncbi.nlm.nih.gov/pubmed/26082616
http://dx.doi.org/10.2147/DDDT.S76358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461130/
https://www.ncbi.nlm.nih.gov/pubmed/26082616
http://dx.doi.org/10.2147/DDDT.S76358

Ejemplares similares